Insider · CIK 0001823996

Galimi Francesco

Reports to the SEC for 2 companies · DEL MAR, CA

sec.gov

Transactions

Companies

Filings

CIK

0001823996

Forms 4 and 5

Insider transactions

47 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-30	GNTAGenenta Science S.p.A. · Stock Option (right to buy)A Award	Director, CMO& Head of Development	AAward	+20K sh	—	—	20,000
2024-06-05	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+375K sh	—	—	375,077
2024-01-24	ACETAdicet Bio, Inc.A Award	SVP & Chief Medical Officer	AAward	+26.3K sh	—	—	101,801
2024-01-24	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+288K sh	—	—	288,134
2024-01-24	ACETAdicet Bio, Inc.F Tax Payment	SVP & Chief Medical Officer	FTax Payment	−4,957 sh	$2.40	−$11.9K	75,501
2023-10-02	ACETAdicet Bio, Inc.F Tax Payment	SVP & Chief Medical Officer	FTax Payment	−8,093 sh	$1.37	−$11.1K	80,458
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+74K sh	—	—	73,964
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	SVP & Chief Medical Officer	DDisposition to Issuer	−74K sh	—	—	0
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+77.3K sh	—	—	77,269
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	SVP & Chief Medical Officer	DDisposition to Issuer	−77.3K sh	—	—	0
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+114K sh	—	—	113,652
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	SVP & Chief Medical Officer	DDisposition to Issuer	−114K sh	—	—	0
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+26.6K sh	—	—	26,625
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+117K sh	—	—	117,200
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	SVP & Chief Medical Officer	DDisposition to Issuer	−117K sh	—	—	0
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+125K sh	—	—	125,000
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	SVP & Chief Medical Officer	DDisposition to Issuer	−125K sh	—	—	0
2023-08-14	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	SVP & Chief Medical Officer	DDisposition to Issuer	−26.6K sh	—	—	0
2023-01-24	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+117K sh	—	—	117,200
2023-01-24	ACETAdicet Bio, Inc.A Award	SVP & Chief Medical Officer	AAward	+26.1K sh	—	—	88,551
2022-10-04	ACETAdicet Bio, Inc.F Tax Payment	SVP & Chief Medical Officer	FTax Payment	−7,933 sh	$14.22	−$113K	62,451
2022-08-04	ACETAdicet Bio, Inc.A Award	SVP & Chief Medical Officer	AAward	+16K sh	—	—	75,917
2022-08-04	ACETAdicet Bio, Inc.F Tax Payment	SVP & Chief Medical Officer	FTax Payment	−5,533 sh	$18.25	−$101K	70,384
2022-04-04	ACETAdicet Bio, Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+6,036 sh	$13.27	+$80.1K	65,953
2022-04-04	ACETAdicet Bio, Inc.S Sale	SVP & Chief Medical Officer	SSale	−168 sh	$21.00	−$3,528	59,917
2022-04-04	ACETAdicet Bio, Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+168 sh	$5.97	+$1,002.96	60,085
2022-04-04	ACETAdicet Bio, Inc.S Sale	SVP & Chief Medical Officer	SSale	−6,036 sh	$21.00	−$127K	59,917
2022-04-04	ACETAdicet Bio, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−1,775 sh	—	—	26,625
2022-04-04	ACETAdicet Bio, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−168 sh	—	—	113,652
2022-04-04	ACETAdicet Bio, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−6,036 sh	—	—	73,964
2022-04-04	ACETAdicet Bio, Inc.S Sale	SVP & Chief Medical Officer	SSale	−1,775 sh	$21.00	−$37.3K	59,917
2022-04-04	ACETAdicet Bio, Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+1,775 sh	$16.82	+$29.9K	61,692
2022-04-01	ACETAdicet Bio, Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+7,621 sh	$5.97	+$45.5K	67,538
2022-04-01	ACETAdicet Bio, Inc.S Sale	SVP & Chief Medical Officer	SSale	−7,621 sh	$21.00	−$160K	59,917
2022-04-01	ACETAdicet Bio, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−7,621 sh	—	—	113,820
2022-02-14	ACETAdicet Bio, Inc.A Award	SVP & Chief Medical Officer	AAward	+16K sh	—	—	65,450
2022-02-14	ACETAdicet Bio, Inc.F Tax Payment	SVP & Chief Medical Officer	FTax Payment	−5,533 sh	$14.27	−$79K	59,917
2022-01-28	ACETAdicet Bio, Inc.A Award	SVP & Chief Medical Officer	AAward	+16K sh	—	—	54,983
2022-01-28	ACETAdicet Bio, Inc.F Tax Payment	SVP & Chief Medical Officer	FTax Payment	−5,533 sh	$11.69	−$64.7K	49,450
2022-01-07	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+125K sh	—	—	125,000
2021-10-01	ACETAdicet Bio, Inc.A Award	SVP & Chief Medical Officer	AAward	+80K sh	—	—	86,983
2021-06-04	ACETAdicet Bio, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	−6,983 sh	—	—	121,441
2021-06-04	ACETAdicet Bio, Inc.M Exercise/Conversion	SVP & Chief Medical Officer	MExercise/Conversion	+6,983 sh	$5.97	+$41.7K	6,983
2021-02-12	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+28.4K sh	—	—	28,400
2021-01-13	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	SVP & Chief Medical Officer	AAward	+80K sh	—	—	80,000
2020-09-17	ACETAdicet Bio, Inc. · Incentive Stock Option (right to buy)A Award	SVP & Chief Medical Officer	AAward	+77.3K sh	—	—	77,269
2020-09-15	ACETAdicet Bio, Inc. · Employee Stock Option (right to buy)A Award	SVP & Chief Medical Officer	AAward	+128K sh	—	—	128,424

Recent filings

Accepted (ET)
Apr 14
Galimi Francesco0001493152-26-014634
SEC(opens sec.gov)
Jun 74
Galimi Francesco0000950170-24-070630
SEC(opens sec.gov)
Jan 264
Galimi Francesco0000950170-24-008051
SEC(opens sec.gov)
Oct 34
Galimi Francesco0001209191-23-051473
SEC(opens sec.gov)
Aug 164
Galimi Francesco0001209191-23-046102
SEC(opens sec.gov)
Jan 264
Galimi Francesco0001209191-23-005044
SEC(opens sec.gov)

Companies

Address

12930 VIA ESPERIA

DEL MAR, CA, 92014